Earnings · China A-shares
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Class A (605033) earnings
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Class A published its Q3 report on 2026-10-21: net profit +43.49% year on year, +52.77% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved -4.08% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-21
- Period end
- 2026-09-30
- Net profit YoY
- +43.49%
- Excl. one-offs YoY
- +52.77%
- Net profit QoQ
- -94.37%
- Result
- Good
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -1.85% | — |
| 3 days | -4.08% | — |
| 7 days | -10.45% | — |
| 14 days | -6.80% | — |
Report history
Over the last 8 reports, net profit grew year on year in 4 of them. The stock rose in the 3 trading days after 5 of 8 reports (average +1.11%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-22 | ¥51.94M | +43.49% | +52.77% | +14.94% | 0.38 | 4.44% | -4.08% | — | — |
| 2026 interim report | 2026-07-30 | ¥51.07M | +41.32% | +45.77% | +14.34% | 0.38 | 4.38% | +6.59% | +20.41% | +20.70% |
| 2026 Q1 report | 2026-04-30 | ¥35.62M | +18.92% | +19.23% | +16.21% | 0.26 | 3.04% | +1.09% | -17.60% | -19.65% |
| 2025 annual report | 2026-04-29 | ¥48.66M | +32.03% | +78.20% | +2.98% | 0.36 | 4.26% | +2.49% | -15.85% | -16.79% |
| 2025 Q3 report | 2025-10-29 | ¥36.20M | -16.36% | -5.57% | -2.23% | 0.27 | 3.18% | +0.35% | -6.61% | -3.14% |
| 2025 interim report | 2025-08-27 | ¥36.14M | -23.81% | -15.09% | -4.76% | 0.27 | 3.20% | -2.97% | -13.50% | -17.28% |
| 2025 Q1 report | 2025-04-29 | ¥29.95M | -32.60% | -27.80% | -7.27% | 0.22 | 2.63% | +5.73% | +38.82% | +36.24% |
| 2024 annual report | 2025-04-26 | ¥36.86M | -35.96% | -48.21% | +26.68% | 0.27 | 3.28% | -0.30% | +35.40% | +32.15% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.